- CA$20.99m
- CA$100.52m
- CA$52.41m
- 36
- 80
- 28
- 46
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.74 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 2.25 | ||
| Price to Sales | 0.42 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -162.36% | ||
| Return on Equity | -120% | ||
| Operating Margin | -43.56% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 7.43 | 10.08 | 23.27 | 47.37 | 52.41 | 48.84 | 50.79 | 50.89% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
LifeSpeak Inc. is a Canada-based provider of mental, physical, and family wellbeing solutions for employers, health plans, and other organizations across the globe. The Company's product verticals include mental health and total wellbeing, physical wellbeing resources, caregiver support and health solutions for substance use disorders (SUD) resources. Its portfolio of solutions includes LifeSpeak Mental Health & Resilience, Wellbeats Wellness, Torchlight Parenting & Caregiving, ALAViDA Substance Use, and LIFT session Fitness. Its curated content library offers digital educational resources including consumable videos, podcasts and articles. Its digital fitness platform (Wellbeats and LIFT session brands) is designed to promote employees' physical health. Its caregiving support platform (Torchlight brand) offers step-by-step guidance on an array of caregiving topics to solve complex family challenges. The Company's SUD treatment platform is delivered through its ALAViDA brand.
Directors
- Nolan Bederman CHM (49)
- Michael Held PRE (49)
- Michael Mckenna CFO (44)
- Stewart Doma FID (38)
- Doug Berkowitz SVP (51)
- Anna Mittag VOP (52)
- Tina Kaichis VPR (50)
- Katie Bowkett VPR (52)
- Danny Weill VPR (44)
- Stanley Bergman MDR (42)
- Mario Di Pietro LED (48)
- Caroline Dadras IND (56)
- Anne Fitzgerald IND (57)
- Sanjiv Samant IND (51)
- Kevin Smith IND (58)
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- January 1st, 2021
- Public Since
- July 6th, 2021
- No. of Employees
- 151
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Toronto Stock Exchange- Shares in Issue
- 59,136,130
- Address
- 49 Wellington St E Suite 301, TORONTO, M5E 1C9
- Web
- https://lifespeak.com/
- Phone
- Auditors
- MNP LLP
Upcoming Events for LSPK
Similar to LSPK
Andlauer Healthcare
Toronto Stock Exchange
Avant Brands
Toronto Stock Exchange
dentalcorp Holdings
Toronto Stock Exchange
Extendicare
Toronto Stock Exchange
Medical Facilities
Toronto Stock Exchange
FAQ
As of Today at 20:46 UTC, shares in Lifespeak are trading at CA$0.36. This share price information is delayed by 15 minutes.
Shares in Lifespeak last closed at CA$0.36 and the price had moved by -47.79% over the past 365 days. In terms of relative price strength the Lifespeak share price has underperformed the Toronto Stock Exchange 300 Composite Index by -58.69% over the past year.
The overall consensus recommendation for Lifespeak is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreLifespeak does not currently pay a dividend.
Lifespeak does not currently pay a dividend.
Lifespeak does not currently pay a dividend.
To buy shares in Lifespeak you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.36, shares in Lifespeak had a market capitalisation of CA$20.99m.
Here are the trading details for Lifespeak:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: LSPK
Based on an overall assessment of its quality, value and momentum Lifespeak is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Lifespeak is CA$0.36. That is 1.41% above the last closing price of CA$0.36.
Analysts covering Lifespeak currently have a consensus Earnings Per Share (EPS) forecast of -CA$0.20 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Lifespeak. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -32.23%.
As of the last closing price of CA$0.36, shares in Lifespeak were trading -32.17% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Lifespeak PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.36.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Lifespeak's management team is headed by:
- Nolan Bederman - CHM
- Michael Held - PRE
- Michael Mckenna - CFO
- Stewart Doma - FID
- Doug Berkowitz - SVP
- Anna Mittag - VOP
- Tina Kaichis - VPR
- Katie Bowkett - VPR
- Danny Weill - VPR
- Stanley Bergman - MDR
- Mario Di Pietro - LED
- Caroline Dadras - IND
- Anne Fitzgerald - IND
- Sanjiv Samant - IND
- Kevin Smith - IND